InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NCI | Ann: Ceasing to be a substantial holder | 08/06/12 | 0 | 217 | |||
|
|||||||
NCI | Ann: Removal from official list at close 12/06/20 | 08/06/12 | 0 | 176 | |||
|
|||||||
NCI | Ann: Suspension from Official Quotation | 28/05/12 | 0 | 243 | |||
|
|||||||
NCI | Ann: Scheme of Arrangement Court Order | 28/05/12 | 0 | 322 | |||
|
|||||||
NCI | Ann: Scheme of Arrangement court approval | 25/05/12 | 0 | 274 | |||
|
|||||||
NCI | Ann: Results of Scheme and General meetings | 21/05/12 | 0 | 170 | |||
|
|||||||
NCI | Ann: Chairmans address NCI Scheme Meeting | 21/05/12 | 0 | 207 | |||
|
|||||||
NCI | Ann: Chairmans address General Meeting | 21/05/12 | 0 | 133 | |||
|
See All Discussions